These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25115512)

  • 41. Benign lymphoid aggregates in the bone marrow: distribution patterns of B and T lymphocytes.
    Naemi K; Brynes RK; Reisian N; Johnston A; Dhillon R; Walavalkar V; Zhao X; Rezk SA
    Hum Pathol; 2013 Apr; 44(4):512-20. PubMed ID: 23063505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.
    Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE
    Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential Pathogenic Impact of Cow's Milk Consumption and Bovine Milk-Derived Exosomal MicroRNAs in Diffuse Large B-Cell Lymphoma.
    Melnik BC; Stadler R; Weiskirchen R; Leitzmann C; Schmitz G
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ontogeny, Genetics, Molecular Biology, and Classification of B- and T-Cell Non-Hodgkin Lymphoma.
    Ryan RJH; Wilcox RA
    Hematol Oncol Clin North Am; 2019 Aug; 33(4):553-574. PubMed ID: 31229154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas.
    Lin J; Lwin T; Zhao JJ; Tam W; Choi YS; Moscinski LC; Dalton WS; Sotomayor EM; Wright KL; Tao J
    Leukemia; 2011 Jan; 25(1):145-52. PubMed ID: 20966935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determining the Origin of Human Germinal Center B Cell-Derived Malignancies.
    Seifert M; Küppers R
    Methods Mol Biol; 2017; 1623():253-279. PubMed ID: 28589362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas.
    Walker SR; Nelson EA; Frank DA
    Oncogene; 2007 Jan; 26(2):224-33. PubMed ID: 16819511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bcl6 promotes follicular helper T-cell differentiation and PD-1 expression in a Blimp1-independent manner in mice.
    Xie MM; Koh BH; Hollister K; Wu H; Sun J; Kaplan MH; Dent AL
    Eur J Immunol; 2017 Jul; 47(7):1136-1141. PubMed ID: 28586108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of Immunophenotyping and Heteroduplex Polymerase Chain Reaction (hPARR) for Diagnosis of Canine Lymphomas.
    Sirivisoot S; Techangamsuwan S; Tangkawattana S; Rungsipipat A
    Asian Pac J Cancer Prev; 2016; 17(6):2909-16. PubMed ID: 27356711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blimp1: driving terminal differentiation to a T.
    Xin A; Nutt SL; Belz GT; Kallies A
    Adv Exp Med Biol; 2011; 780():85-100. PubMed ID: 21842367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
    Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST
    Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphoma and the control of B cell growth and differentiation.
    Rui L; Goodnow CC
    Curr Mol Med; 2006 May; 6(3):291-308. PubMed ID: 16712476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation.
    Diehl SA; Schmidlin H; Nagasawa M; van Haren SD; Kwakkenbos MJ; Yasuda E; Beaumont T; Scheeren FA; Spits H
    J Immunol; 2008 Apr; 180(7):4805-15. PubMed ID: 18354204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. B cell receptor-ERK1/2 signal cancels PAX5-dependent repression of BLIMP1 through PAX5 phosphorylation: a mechanism of antigen-triggering plasma cell differentiation.
    Yasuda T; Hayakawa F; Kurahashi S; Sugimoto K; Minami Y; Tomita A; Naoe T
    J Immunol; 2012 Jun; 188(12):6127-34. PubMed ID: 22593617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rimming of adipocytes by neoplastic lymphocytes: a histopathologic feature not restricted to subcutaneous T-cell lymphoma.
    Lozzi GP; Massone C; Citarella L; Kerl H; Cerroni L
    Am J Dermatopathol; 2006 Feb; 28(1):9-12. PubMed ID: 16456318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
    Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
    Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The zinc finger transcriptional repressor Blimp1/Prdm1 is dispensable for early axis formation but is required for specification of primordial germ cells in the mouse.
    Vincent SD; Dunn NR; Sciammas R; Shapiro-Shalef M; Davis MM; Calame K; Bikoff EK; Robertson EJ
    Development; 2005 Mar; 132(6):1315-25. PubMed ID: 15750184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TOX expression in cutaneous B-cell lymphomas.
    Schrader AM; Jansen PM; Willemze R
    Arch Dermatol Res; 2016 Aug; 308(6):423-7. PubMed ID: 27180090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.